acute myeloid. Acute myeloblastic leukaemia, minimal differentiation Acute myeloblastic leukaemia (with maturation) AML1/ETO AML M0 AML M1 AML M2 AML with t(8
Conditions
Interventions
Intervention 1: The control group did not receive hypnosis therapy in the treatment of related audio hypnosis sessions were provided. Intervention 2: First meeting: Introduction to Trading Had- AML pa
Behavior
The control group did not receive hypnosis therapy in the treatment of related audio hypnosis sessions were provided
First meeting: Introduction to Trading Had- AML patients with Hypnosis- view color images of standard questions related to sexual disease medications, chemotherapy expectations, relaxation and get pub
Sponsors
Islamic Azad University Sari Branch
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: The age group between 18 and 50 years- completed consent form to participate in the plan- absence of severe depression with- absence seizures are not controlled- absence of anti social character- psychosis had no- medical record at the clinic of Imam Khomeini hospital- gardener and get diagnosed acute myeloid leukemia by flow cytometry test Exclusion criteria: Each treatment when the patient can be removed from the plan.- The experimental group hypnosis therapy done by indoctrinating during six 40-minute sessions- control group received hypnosis therapy- gardeners with no medical record at the clinic and Imam Khomeini hospital in Sari city- with no testing of flow cytometry for the detection of acute myeloid leukemia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before Intervention In The First Session And After The last Intervention At An Interval Of 3 Months In The last Session. Method of measurement: Inventory McGill Pain Management.;Anxiety Death. Timepoint: Before Intervention In The First Session And After The last Intervention At An Interval Of 3 Months In The last Session. Method of measurement: Questionnaires Collett-Lester Anxiety Death.;Resiliency. Timepoint: Before Intervention In The First Session And After The last Intervention At An Interval Of 3 Months In The last Session. Method of measurement: Questionnaires Resilience Cooner And Davidson.;Cure Of Cancer Cells. Timepoint: Before Intervention In The First Session And After The last Intervention At An Interval Of 3 Months In The last Session. Method of measurement: Flow Cytometry Tests To Measure CD4 And CD8 Markers Aand Measuring The Ratio Of CD4 To CD8 lymphocyte Percentage ,easurements. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhasem Janbabai
Mazandaran University of Medical Sciences
Outcome results
None listed